Recap: Relmada Therapeutics Q4 Earnings
Recap: Relmada Therapeutics Q4 Earnings
Relmada Therapeutics (NASDAQ:RLMD) reported its Q4 earnings results on Tuesday, March 19, 2024 at 04:15 PM.
Relmada Therapeutics（納斯達克股票代碼：RLMD）於2024年3月19日星期二下午4點15分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Relmada Therapeutics missed estimated earnings by -1.0%, reporting an EPS of $-0.84 versus an estimate of $-0.83.
Relmada Therapeutics報告的每股收益爲-0.84美元，未達到預期的-1.0％，而預期的收益爲-0.83美元。
Revenue was down $0 from the same period last year.
收入比去年同期下降了0美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.18 which was followed by a 0.0% increase in the share price the next day.
上個季度，該公司的每股收益高出0.18美元，隨後第二天股價上漲了0.0％。
To track all earnings releases for Relmada Therapeutics visit their earnings calendar here.
要追蹤Relmada Therapeutics發佈的所有業績，請在此處訪問他們的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。